Duloxetine on Bone Metabolism
Unknown statusNCT05550506
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of the study was to determine the effect of duloxetine as monotherapy on biochemical markers and bone mineral density.
Study details
- Official title
- The Effect of Duloxetine on Bone Metabolism
- Conditions
- Interventions
- Sponsor
- Cukurova University
- Start date
- 2022-07-27
- Primary completion
- 2022-10-01
- Sex
- All
- Age range
- from 18 Years to 50 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * \>18 years or \<50 years * patients using duloxetine for at least 3 months due to chronic pain or fibromyalgia Exclusion Criteria: * postmenopausal women * clinical conditions which cause secondary osteoporosis * patients using medication that cause secondary osteoporosis * pregnancy and malignity
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05550506